Hongli Group Provides Strategic Update on Proposed Advanced Battery Collaboration as Xell Energy Achieves Drone Customer Design WinsPRNewsWire · Oct 13, 2026
Helus Pharma: A Buy Ahead Of The HLP003 Phase 3 ReadoutSeeking Alpha · Oct 11, 2026
Hongli Group Inc. Announces Appointment of Mr. Michael W.PRNewsWire · Oct 5, 2026
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major DepressionMarketBeat · Sep 24, 2026
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026GlobeNewsWire · Sep 21, 2026
Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major CatalystSeeking Alpha · Aug 21, 2026Hongli Group Inc., through its affiliated entities, specializes in the engineering, tailoring, production, and distribution of cold roll-formed steel profiles. These precision components are utilized in a variety of machinery and equipment, with a market reach that extends across the People's Republic of China, South Korea, Japan, the United States, and Sweden. The company's products cater to essential sectors such as mining and excavation, construction, agriculture, and transportation.